Top Scoops

Book Reviews | Gordon Campbell | Scoop News | Wellington Scoop | Community Scoop | Search

 

Peter Rost: Clueless Pfizer Executives

Clueless Pfizer Executives


By Peter Rost, M.D.

On Thursday, November 30, Pfizer’s executives conducted a well rehearsed dog-and-pony show over at Pfizer’s research facilities in Groton, CT. All interest was focused on torcetrapib; the most important new drug in Pfizer's pipeline, which boosts good cholesterol.

According to Forbes, Pfizer Chief Executive Jeffrey Kindler told about 250 analysts and investors attending the meeting that torcetrapib was "one of the most important developments in our generation."

Pfizer research president John LaMattina said, "We believe this is the most important new development in cardiovascular medicine in years,"according to the Wall Street Journal.

On Saturday, December 2—two days later—Pfizer said in a statement that it is terminating all clinical tests of torcetrapib and its plans to bring the drug to market. A board of independent experts had reviewed the latest data from a 15,000-patient test on torcetrapib and found that patients on the drug were dying like flies; almost twice as many dead as on the comparator. The company also said it is asking doctors participating in studies of torcetrapib to tell patients to stop taking the drug immediately.

Associated Press concluded, “The news is devastating to Pfizer, which had been counting on the drug to revitalize stagnant sales that have been hurt by numerous patent expirations on key products. It has said it was spending around $800 million to develop torcetrapib.”

Of course, in the drug industry, bad stuff happens. But in this particular case, the whole scientific world had been worried about the fact that torcetrapib raises blood pressure. Not a good thing for a cardiovascular drug. But that didn't stop the Pfizer executives from hyping torcetrapib. Until it turned out that "one of the most important developments in our generation" was really a killer drug—quite literally.

And this is what makes Pfizer‘s CEO Mr. Kindler and Pfizer’s research chief Dr. LaMattina officially the most clueless executives in the drug business.

*************

Peter Rost, M.D., is a former Vice President of Pfizer. He became well known in 2004 when he emerged as the first drug company executive to speak out in favor of reimportation of drugs. He is the author of “The Whistleblower, Confessions of a Healthcare Hitman,” http://the-whistleblower-by-peter-rost.blogspot.com/. He also writes the daily "Dr. Peter Rost blog," http://peterrost.blogspot.com/

© Scoop Media

 
 
 
Top Scoops Headlines

 

27-29 Sept: Social Enterprise World Forum Live Blog

1600+ delegates from more than 45 countries have came together to share wisdom, build networks and discuss how to create a more sustainable future using social enterprise as a vehicle. Attending the Forum were social enterprise practitioners, social entrepreneurs, policy makers, community leaders, investors, activists, academics and more from across the globe... More>>

HiveMind Report: A Universal Basic Income For Aotearoa NZ

Results from this HiveMind suggests that an overwhelming majority of Kiwis believe that due to changing circumstances and inefficiencies in the current system, we need a better system to take care of welfare of struggling members in our society. More>>

ALSO:

Scoop Hivemind: Medical Cannabis - Co-Creating A Policy For Aotearoa

Welcome to the fourth and final HiveMind for Scoop’s Opening the Election campaign for 2017. This HiveMind explores the question: what would a fair, humane and safe Medical Cannabis policy look like for Aotearoa, NZ in 2018? More>>

ALSO:

Lyndon Hood: Notes On National’s Election Campaign, In Poem Form

Nationyl’s bitumen-ing / As they du du / Seed groweth / River floweth / Then ‘dozer drives thru / Highway ensu. More>>